Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients

Lu, Lu; Wing-Yee Mok, Bobo; Lei Chen, Lin; Man Chun Chan, Jacky; T. Y. Tsang, O.; Lam, Bosco; Wai Man Chuang, Vivien; Wing Ho Chu, Allen; Mui Chan, Wan; Daniel Ip, Jonathan; Pui Chun Chan, Brian; Zhang, Ruiqi; Chik Yan Yip, Cyril; Chi‐Chung Cheng, Vincent; Hung Chan, Kwok; Jin, Dong‐Yan; Fan Ngai Hung, Ivan; Yung Yuen, Kwok; Chen, Honglin; Kai Wang To, Kelvin

doi:10.1093/cid/ciab1041

Public

Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients

Published in Clinical Infectious Diseases • Dec 15, 2021

Authors:

Lu Lu

Bobo Wing-Yee Mok

Lin Lei Chen

Abstract

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant, designated as a variant of concern by the World Health Organization, carries numerous spike mutations that are known to evade neutralizing antibodies elicited by coronavirus disease 2019 (COVID-19) vaccines...

Subject

Virology

Neutralization

Neutralizing antibody

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!